Selvita strengthens management structure in sales and drug development segment
Go back to Selvita strengthens management structure in sales and drug development segment| ISHARES SILVER TRUST (NYSE: SLV) | Delayed: 61.59 -0.73 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.32 | 52 Week High | $19.71 | |||
| Open | $61.59 | 52 Week Low | $13.04 | |||
| Day High | $61.96 | P/E | N/A | |||
| Day Low | $61.02 | EPS | $0.00 | |||
| Volume | 12,525,321 | |||||
| ISHARES SILVER TRUST (NYSE: SLV) | Delayed: 61.59 -0.73 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.32 | 52 Week High | $19.71 | |||
| Open | $61.59 | 52 Week Low | $13.04 | |||
| Day High | $61.96 | P/E | N/A | |||
| Day Low | $61.02 | EPS | $0.00 | |||
| Volume | 12,525,321 | |||||

